In an effort to reverse the rapidly rising death toll from heroin, prescription drugs, and opioids across the U.S. which has recently risen to surpass automobile accidents as the leading cause of injury-related deaths according to the CDC, legislation has been drafted in a rare bipartisan effort.

The Comprehensive Addiction and Recovery Act (CARA)
Designed to strengthen prescription drug monitoring programs, better trace the diversion of opioid drugs, and increase promotion and access to addiction recovery services, CARA will also open up a variety of prevention and treatment avenues:

  • Prevention and education efforts designed to prevent methamphetamine, opioid, and heroin abuse.
  • Increased availability of Naloxone, an opioid overdose reversal agent, to first responders and law enforcement personnel.
  • Disposal sites for unwanted prescriptions.
  • Resources to identify and treat incarcerated individuals suffering opioid-related addiction disorders.

Well On Its Way
The bill has been approved by the House and the Senate, with both parties offering broad support. It is the first time in decades Congress has passed comprehensive addiction legislation, and the first time in history they’ve supported long-term addiction recovery. CARA is now on its way to the President’s desk, where it is expected to be signed into law. Mr. Obama has already requested $1.1 billion in funds toward the fight against opioid addiction.

Taking Action
Do you wish there was something you could do now to help in the fight against the nation’s continually rising opioid epidemic? You don’t have to wait on CARA to start making a difference. ANS Solutions proprietary Pharmacotherapy Review helps curtail costly and potentially dangerous pharmaceutical treatment regimens, ensuring optimal patient outcomes through expert knowledge and evidence-based, alternative treatment methods devised face-to-face with the help of treating doctors. Discover the difference an actionable drug utilization review can make. Contact https://ans-solutions.com today.